Trinity Biotech (TRIB) Current Leases (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Current Leases for 9 consecutive years, with $2.3 million as the latest value for Q4 2024.
- Quarterly Current Leases rose 34.89% to $2.3 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2024, up 34.89% year-over-year, with the annual reading at $2.3 million for FY2024, 34.89% up from the prior year.
- Current Leases hit $2.3 million in Q4 2024 for Trinity Biotech, up from $1.7 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.3 million in Q4 2024 to a low of $1.7 million in Q4 2022.
- Historically, Current Leases has averaged $2.0 million across 5 years, with a median of $2.0 million in 2021.
- Biggest five-year swings in Current Leases: decreased 15.35% in 2022 and later soared 34.89% in 2024.
- Year by year, Current Leases stood at $2.2 million in 2020, then fell by 8.04% to $2.0 million in 2021, then fell by 15.35% to $1.7 million in 2022, then grew by 1.07% to $1.7 million in 2023, then soared by 34.89% to $2.3 million in 2024.
- Business Quant data shows Current Leases for TRIB at $2.3 million in Q4 2024, $1.7 million in Q4 2023, and $1.7 million in Q4 2022.